Chemical Component Summary

Name3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile
SynonymsPT2385
Identifiers3-[[(1~{S})-2,2-bis(fluoranyl)-7-methylsulfonyl-1-oxidanyl-1,3-dihydroinden-4-yl]oxy]-5-fluoranyl-benzenecarbonitrile
FormulaC17 H12 F3 N O4 S
Molecular Weight383.342
TypeNON-POLYMER
Isomeric SMILESCS(=O)(=O)c1ccc(c2c1[C@@H](C(C2)(F)F)O)Oc3cc(cc(c3)F)C#N
InChIInChI=1S/C17H12F3NO4S/c1-26(23,24)14-3-2-13(12-7-17(19,20)16(22)15(12)14)25-11-5-9(8-21)4-10(18)6-11/h2-6,16,22H,7H2,1H3/t16-/m0/s1
InChIKeyONBSHRSJOPSEGS-INIZCTEOSA-N

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count1
Bond Count40
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB16055 
NamePT-2385
Groups investigational
DescriptionPT-2385 is under investigation in clinical trial NCT03108066 (PT2385 for the Treatment of Von Hippel-lindau Disease-associated Clear Cell Renal Cell Carcinoma).
SynonymsPT-2385
CAS number1672665-49-4

Related Resource References

Resource NameReference
Pharos CHEMBL4173075
PubChem 91754484
ChEMBL CHEMBL4173075